BlackRock Investment Management, LLC - LA JOLLA PHARMACEUTICAL CO ownership

LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 54 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q2 2015. The put-call ratio across all filers is 0.44 and the average weighting 0.6%.

Quarter-by-quarter ownership
BlackRock Investment Management, LLC ownership history of LA JOLLA PHARMACEUTICAL CO
ValueSharesWeighting
Q4 2016$986,000
-25.9%
56,235
+0.6%
0.00%
-50.0%
Q3 2016$1,330,000
+57.6%
55,913
+6.0%
0.00%
+100.0%
Q2 2016$844,000
-17.5%
52,724
+7.8%
0.00%0.0%
Q1 2016$1,023,000
-20.6%
48,920
+2.5%
0.00%
-50.0%
Q4 2015$1,289,000
-2.3%
47,750
+0.6%
0.00%0.0%
Q3 2015$1,319,000
+33.0%
47,469
+17.2%
0.00%
+100.0%
Q2 2015$992,000
+2581.1%
40,486
+1886.6%
0.00%
Q1 2015$37,0000.0%2,038
+2.5%
0.00%
Q4 2014$37,000
+85.0%
1,988
-5.0%
0.00%
Q3 2014$20,000
+122.2%
2,093
+103.4%
0.00%
Q2 2014$9,0001,0290.00%
Other shareholders
LA JOLLA PHARMACEUTICAL CO shareholders Q2 2015
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 2,872,130$77,548,00030.77%
RTW INVESTMENTS, LP 1,084,416$29,279,0009.67%
Avoro Capital Advisors LLC 784,199$21,173,0007.29%
Broadfin Capital, LLC 1,165,373$31,465,0001.94%
P.A.W. CAPITAL CORP 50,400$1,361,0001.54%
Belmont Global Advisors, Inc. 37,522$1,013,0001.31%
Perceptive Advisors 649,515$17,537,0001.30%
ACUTA CAPITAL PARTNERS, LLC 82,920$2,239,0001.07%
Iguana Healthcare Management, LLC 110,000$2,970,0000.98%
Virtus ETF Advisers LLC 10,250$277,0000.76%
View complete list of LA JOLLA PHARMACEUTICAL CO shareholders